Acelyrin Inc is a late-stage clinical biopharmaceutical company. It is focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of promising drug candidates.
This is not a financial advice!
Upcoming catalyst on 31st. of March
We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.
10.76% short float
Rel. Vol. at 2.48
Block buys and Passive Stakes
Keep an eye on 10.0, 13.0 levels, needs to get broken for a further upmove. You can take partial profits at these levels if u want to lock in gains.
SL under 7.2
TP approx. 16 ( if we fill the gap we might go to 27)
Most info on the chart.
Trade carefully!